Skip to main content
. 2023 Mar 17;56(3):526–536. doi: 10.1016/j.jmii.2023.03.003

Table 2.

Detectable T cells reactive to SARS-CoV-2 proteins M, N and S.

All patients (n = 30) LT recipients (n = 15) Immunocompetent controls (n = 15) p
Reactive CD3+CD4+ T cells
 Against protein M 29 (96.7) 15 (100) 14 (93.3) >0.99
 Against protein N 25 (83.3) 12 (80) 13 (86.7) >0.99
 Against protein S 30 (100) 15 (100) 15 (100) >0.99
Reactive CD3+CD8+ T cells
 Against protein M 28 (93.3) 13 (86.7) 15 (100) 0.483
 Against protein N 17 (56.7) 9 (60) 8 (53.3) >0.99
 Against protein S 23 (76.7) 12 (80) 11 (73.3) >0.99

Data are expressed as n (%).